Integration

Fyllo | Semasio’s New CEO Appoints His First Executives

Retrieved on: 
Thursday, March 14, 2024
Growth, CFO, MacAndrews & Forbes, Integration, Accounting, Yahoo! Inc. (2017–present), Strategic planning, Alternate route, CCO, Management

As CFO at Fyllo, Ying leads the finance, accounting, and strategic planning functions at the company along with the executive team.

Key Points: 
  • As CFO at Fyllo, Ying leads the finance, accounting, and strategic planning functions at the company along with the executive team.
  • Prior to Fyllo, Ying was a VC investor with several early-stage funds including Integrated VC, a psychedelics and technology focused investment fund.
  • “I am thrilled to join the team at Fyllo | Semasio during a time when there is such great potential for both innovation and impact.
  • Pinkham's track record in driving commercial success and building strategic partnerships will be crucial as Fyllo | Semasio expands its market reach.

Brevo Unveils Commerce Suite for Retail and E-Commerce Customers

Retrieved on: 
Thursday, March 14, 2024
Unify, SMS, CRM, WhatsApp, Social media, Growth, Integration, Communication, Online shopping

With 30 percent of its existing customers in the retail and e-commerce industries, Brevo Commerce Suite will accelerate the company’s position in the global e-commerce market, which is projected to be worth $8 trillion by 2027 .

Key Points: 
  • With 30 percent of its existing customers in the retail and e-commerce industries, Brevo Commerce Suite will accelerate the company’s position in the global e-commerce market, which is projected to be worth $8 trillion by 2027 .
  • Consumer demand for better customer experience continues to grow in line with the rapid growth of the global e-commerce market.
  • With the Brevo Commerce Suite, merchants can analyze the full spectrum of their customers’ purchasing habits across all channels, allowing them to send more personalized recommendations.
  • “Today’s merchants face fierce competition when it comes to attracting and retaining customers,” said Armand Thiberge, CEO and founder of Brevo.

PSA Certified Announces New PSA Certified Level 4 Certification and Continued Partner Growth

Retrieved on: 
Thursday, April 4, 2024
Software, Mobile, Wireless, Networks, Internet, Hardware, Electronic Design Automation, Data Management, Consumer Electronics, IOT (Internet of Things), Technology, Artificial Intelligence, Security, Telecommunications, IOS, Theft, Certification, Ise, Rot, OTA, Original equipment manufacturer, PSA Certified, Internet of things, Infineon Technologies, Integration, Trust anchor, Electronics, Rest, AI, Near-field communication, Confidentiality, Machine learning, PSA, Legislation, Medical device

Benefits of PSA Certified Level 4 iSE / SE Certification include:

Key Points: 
  • Benefits of PSA Certified Level 4 iSE / SE Certification include:
    PSA Certified Level 4 iSE/SE considers more sophisticated attack methods in scope.
  • A trusted subsystem that achieves PSA Certified Level 4 iSE/SE can be used through composition in a PSA Certified Level 3+SE certification of the full PSA RoT security functionality.
  • The PSA Certified Level 3 document has been updated to allow this new certification level.
  • The first partner to aim for the PSA Certified Level 4 iSE/SE standard is Infineon , showcasing its commitment to developing IoT devices to the highest security-by-design standards.

Oligonucleotides Global Markets Report 2024: Historical Market Revenue Data from 2020 to 2022, Estimates for 2023, and CAGR Projections through 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 3, 2024
Biotechnology, General Health, Health, Genetics, Pharmaceutical, Diagnosis, Cytomegalovirus retinitis, PCR, Eurofins Scientific, Thermo Fisher Scientific, Disease, Oligonucleotide, CMV, ESG, Integration, Estimation, Research, RNA, DNA, Cancer, Competition, Infection, Agilent Technologies, Hepatitis, Spinal cord, In situ hybridization, Therapy, USD, FDA, Liver, Polymerase chain reaction, Fine chemical

The Global Oligonucleotides Market was valued at USD 7 Billion in 2023, and is expected to reach USD 11.7 Billion by 2028, rising at a CAGR of 11.00%.

Key Points: 
  • The Global Oligonucleotides Market was valued at USD 7 Billion in 2023, and is expected to reach USD 11.7 Billion by 2028, rising at a CAGR of 11.00%.
  • This report covers the worldwide market for oligonucleotide synthesis, which consists of four main product types: oligonucleotide drugs, synthesized oligos, equipment and reagents, and services.
  • Based on application, the market for oligonucleotide synthesis is divided into research diagnostics and therapeutics.
  • The report also covers approved drugs, the oligonucleotide synthesis process, innovative research, opportunities within the market and profiles of leading companies in the oligonucleotide synthesis industry.

Spok Achieves Top Client Satisfaction Scores for Seventh Consecutive Year

Retrieved on: 
Tuesday, April 2, 2024
Mental Health, Technology, Managed Care, General Health, Hospitals, Nursing, Health, Health Technology, Security, Apps, Applications, Other Technology, Telecommunications, Software, Other Health, Mobile, Wireless, Data Management, Practice Management, Interface, Management, Customer service, Communication, Computer security, RCM, Integration, Marketing communications, Privacy by design, Privacy, Marketing, Trust, Accountability, Compensation, SPOK, VBC

Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a leader in healthcare communications, earned top honors for the seventh consecutive year in a survey of healthcare industry clients by Black Book Market Research on top-rated clinical communications platforms.

Key Points: 
  • Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a leader in healthcare communications, earned top honors for the seventh consecutive year in a survey of healthcare industry clients by Black Book Market Research on top-rated clinical communications platforms.
  • Black Book Market Research LLC measures customer satisfaction across eighteen copyrighted key performance indicators: Strategic Alignment of Client Goals including VBC, RCM & Telehealth; Innovation and Optimization; Training and Education; Client Relationships and Cultural Fit; Trust, Accountability, Transparency, Ethics; Breadth of Offerings, Client Types, Delivery Excellence; Deployment and Implementation; Customization; Integration and Interfaces; Scalability, Client Adaptability, Flexible Pricing; Compensation and Employee Performance; Reliability; Brand Image and Marketing Communications; Marginal Value Adds and Modules; Financial Stability & Managerial Viability; Data Security, Patient Privacy, and Backup Services; Account Management Support and Customer Care; and Best of Breed Technology and Process Improvement.
  • Black Book's independent user surveys aim to inform healthcare technology buyers about vendors exceeding expectations, as rated by current and former customers across all organizational user levels.
  • For methodology, auditing, resources, comprehensive research, and ranking data, see http://blackbookmarketresearch.com .

Global and Regional MRD Testing Market Analysis Report 2024: Revolutionizing Cancer Patient Management, Rising Consumer Awareness Spurs Demand for MRD Testing - Forecast to 2033 - ResearchAndMarkets.com

Retrieved on: 
Monday, April 1, 2024
Surgery, Medical Devices, Hospitals, Genetics, Health Technology, Biotechnology, Radiology, Health, Oncology, Hospital, PCR, Flow cytometry, Chronic leukemia, Growth, Bone marrow, Incidence, Integration, Patient, NGS, IDT, Research, Health care, Multiple myeloma, Acquisition, Cancer, Medicare, Medicine, Karyotype, MRD, Haematopoietic system, Region, GRAIL, Throttle position sensor, Lymphoma, Polymerase chain reaction, Medical imaging

The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and Region Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and Region Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • The MRD testing market is driven by several factors, including the expansion in medicare coverage for MRD testing and the administration of solid tumor diagnosis.
  • In recent years, as consumer awareness has grown, there has been an increasing demand for MRD testing.
  • The global MRD testing market is a rapidly growing segment in the healthcare industry, driven by the increasing demand for accurate and sensitive methods to monitor and manage cancer patients.

UiPath Announces Sebastian Schrötel Joins Product Leadership Team to Lead UiPath Autopilot™ and Developer Experiences

Retrieved on: 
Monday, April 1, 2024
Networks, Data Management, Technology, Artificial Intelligence, Software, Business process automation, Improper integral, Partnership, Test suite, Business administration, Knowledge, Integration, SAP, Information, AI, Senior, Mannheim Business School, Application development, Product management, Integration platform, Management

UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced Sebastian Schrötel is joining the company as Senior Vice President of Product Management.

Key Points: 
  • UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced Sebastian Schrötel is joining the company as Senior Vice President of Product Management.
  • Schrötel reports to Chief Product Officer Graham Sheldon and will lead the company’s strategy for products including UiPath Autopilot™ , UiPath Studio and developer experiences, and UiPath Integration Service .
  • Schrötel will also lead the company’s development of business in the Integration Platform as a Service (iPaaS) market.
  • “Sebastian will lead UiPath Autopilot, which combines generative AI and specialized AI to enhance productivity and democratize automation across the enterprise.

CAPITAL BANCORP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Capital Bancorp, Inc. - CBNK

Retrieved on: 
Friday, March 29, 2024
Class Action Lawsuit, Professional Services, Legal, KSF, Integration, Capital, Sale

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Capital Bancorp, Inc. (NasdaqGS: CBNK) (“the Company”) and Integrated Financial Holdings, Inc.

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Capital Bancorp, Inc. (NasdaqGS: CBNK) (“the Company”) and Integrated Financial Holdings, Inc.
  • Under the terms of the proposed transaction, Integrated shareholders will receive, subject to certain adjustments, $5.36 in cash and 1.115 shares of Capital common stock for each share of Integrated common stock.
  • KSF is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company’s shareholders.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

Philip Morris International Demonstrates Clear Progress Toward Its Purpose as It Releases 2023 Integrated Report

Retrieved on: 
Thursday, March 28, 2024
Sustainability, Environment, Environmental, Social and Governance (ESG), Tobacco, Professional Services, Consumer, Other Consumer, Retail, Smoke, Philip Morris International, Integration, Materiality, History, Sale, Child, Science, Quality of life, GRI, Intellectual property, United Nations Global Compact, Marketing, Dow Jones, Science Based Targets initiative, FLAG, Information, Woman, ISS, Privacy, Food, Prevalence, ESG, PMI, Research, Classification, Heated tobacco product, Investment, Dow Jones Sustainability Indices, Targets, Farmer, COVID-19, Life, ZYN, Biodiversity, Smoking, Water, IQOS, Toxicology, World Bank

Please visit pmi.com/sustainability to learn more, and read the full 2023 Integrated Report , case studies and market stories , and the Sustainability KPI Protocol 2023 .

Key Points: 
  • Please visit pmi.com/sustainability to learn more, and read the full 2023 Integrated Report , case studies and market stories , and the Sustainability KPI Protocol 2023 .
  • 2 For definition of net revenues related to smoke-free products, see Glossary available on pages 208-212 of PMI Integrated Report 2023.
  • 3 For definition of available for sale, see Glossary available on pages 208-212 of PMI Integrated Report 2023.
  • For definition of low- and middle-income markets, see Glossary available on pages 208-212 of PMI Integrated Report 2023.

CBNK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Capital Bancorp, Inc. Is Fair to Shareholders

Retrieved on: 
Thursday, March 28, 2024
Class Action Lawsuit, Professional Services, Legal, Integration, Fraud, Advertising, Capital, Security (finance)

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Capital Bancorp, Inc. (NASDAQ: CBNK) and Integrated Financial Holdings, Inc. is fair to Capital shareholders.

Key Points: 
  • Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Capital Bancorp, Inc. (NASDAQ: CBNK) and Integrated Financial Holdings, Inc. is fair to Capital shareholders.
  • Per the terms of the proposed transaction, Integrated shareholders will, subject to certain adjustments, receive $5.36 in cash and 1.115 shares of Capital common stock for each share of Integrated common stock.
  • Upon closing of the proposed transaction, Capital shareholders will own approximately 84% of the combined company.
  • On behalf of Capital shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.